Arkolith/Insider Trading/MAIA/Form 4

Smith Stan

DirectorMAIA Biotechnology, Inc. (MAIA) · full profile →Form 4 · filed Nov 4, 2024
Net Buying
Open-Market Buys
$251K
Open-Market Sells
$0
Net Open-Market Flow
$251K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 1, 2024Buy(P)100K$2.51$251K958K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 1, 2024Buy(P)100K$2.26$226K100K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001127602-24-026376) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML